VROC Investigators
Leadership
Research interests:
- Effect of SAbR on immune function and immunotherapy
- Hypofractionated radiation therapy
- Radiation response modifiers
- Stereotactic body radiation therapy
Research interests:
- Intratumoral immunotherapy with nanoparticles
- Treating veterinary cancers with drug plus device combinations
- Focused ultrasound mediated nanotherapy
Investigators
Research interests:
- Understand factors that influence immune heterogeneity in the tumor microenvironment
- Investigate mechanisms of immune privilege that can enhance immunotherapy efficacy
- Explore tolerogenic and immunogenic mechanisms activated by radiation
Research interests:
- Molecular mechanisms of endocrine therapy- and CDK 4/6 inhibitor-resistance in breast cancer
- Targeting epigenetic pathways to overcome treatment resistance in breast cancer
- New therapeutic approaches to mitigate radiation-induced heart disease
Research interests:
- Cellular response to DNA damage
- The role of aberrant DNA repair and signaling in cancer etiology
- The role of the DNA-PK complex in repairing DNA damage
Research interests:
- Adaptive radiotherapy
- Artificial intelligence in modern radiation therapy
- Functional oncological MRI
- MRI-guided radiation therapy
Research interests:
- Innate and adaptive immune responses generated by tumor irradiation with stereotactic ablative radiotherapy (SAbR)
- Investigate strategies to combine immunotherapy with SAbR (i-SAbR) for cancer treatment
- Improve cancer patient treatment outcome through the design of i-SAbR clinical trials
Research interests:
- Artificial intelligence in medicine
- GPU and cloud based automated treatment planning
- On-line re-planning for adaptive radiotherapy
Research interests:
- Adaptive proton therapy
- Artificial intelligence
- FLASH
- PET imaging
- PULSAR
Research interests:
- Online adaptive radiation therapy
- Hadron (particle) therapy
- Biology-guided radiation therapy
Research interests:
- Immunomodulatory effect of radiation therapy
- Innate immunity DNA-sensing pathways
- Monoclonal antibodies and immunoconjugates as cancer immunotherapy
- Clinical research in oncology
Research interests:
- The role of DAB2IP in chromosome stability
- Developing physiologically relevant tumor models that improve preclinical predictions and translational success
- Developing drug delivery system using nanoparticles
Research interests:
- Nanomedicine approaches to improve cancer treatment, including radiation therapy and immunotherapy
- Development of novel cancer diagnostics and therapeutics using biomedical engineering approaches
- Understand cancer metastasis biology by applying tissue engineering technologies
- Development of novel therapeutic approaches to treat autoimmune diseases
Research interests:
- Biomedical optics
- In vivo cell tracking
- Optical tomography-guided radiation therapy
- Ultra-high-dose rate irradiation
Research interests:
- Structural biology of cancer-associated proteins
- Drug development for cancer therapy
- Biochemistry and chemical biology